发明名称 HETEROCYCLIC COMPOUND
摘要 The present invention addresses the problem of providing a compound that has excellent ROR?t-inhibiting effects and is useful as a preventive or therapeutic agent for psoriasis, inflammatory bowel disease, ulcerative colitis, Crohn's disease, rheumatoid arthritis, multiple sclerosis, uveitis, asthma, ankylosing spondylitis, systemic lupus erythematosus, chronic obstructive pulmonary disease, etc. The present invention relates to a compound represented by formula (I): [In the formula, each reference is as set forth in the Specification.] or a salt thereof and relates to a compound that has ROR?t-inhibiting effects and is useful as a preventive or therapeutic agent for psoriasis, inflammatory bowel disease, ulcerative colitis, Crohn's disease, rheumatoid arthritis, multiple sclerosis, uveitis, asthma, ankylosing spondylitis, systemic lupus erythematosus, chronic obstructive pulmonary disease, etc.
申请公布号 CA2961033(A1) 申请公布日期 2016.03.17
申请号 CA20152961033 申请日期 2015.09.10
申请人 TAKEDA PHARMACEUTICAL COMPANY LIMITED 发明人 YAMAMOTO, SATOSHI;SHIRAI, JUNYA;ODA, TSUNEO;IMADA, TAKASHI;KONO, MITSUNORI;SATO, AYUMU;TOMATA, YOSHIHIDE;OCHIDA, ATSUKO;ISHII, NAOKI;SASAKI, YUSUKE;FUKASE, YOSHIYUKI;YUKAWA, TOMOYA;FUKUMOTO, SHOJI
分类号 C07D239/96;A61K31/517;A61K31/5377;A61K31/541;A61K31/55;A61K31/551;A61P1/00;A61P11/00;A61P11/06;A61P17/00;A61P19/00;A61P19/02;A61P25/00;A61P29/00;A61P37/02;A61P37/08;A61P43/00;C07D401/06;C07D401/12;C07D401/14;C07D403/12;C07D405/12;C07D405/14;C07D409/14;C07D413/06;C07D413/12;C07D413/14;C07D417/12;C07D417/14;C07D471/04 主分类号 C07D239/96
代理机构 代理人
主权项
地址